Pakistani health tech platform raises $6 million to expand across GCC
MedIQ was founded by Dr. Saira Siddiqui, a doctor who holds a PhD in Health Economics from the University of Yorkshire, in 2020 in Pakistan's capital Islamabad.
The startup aims to redefine health care through a digitally enabled hybrid ecosystem and is currently operating in Pakistan, Saudi Arabia, the United Arab Emirates (UAE) and Canada.
'This over-subscribed round signals strong investor confidence in our accelerated market traction, validates our excellence in engineering to support in becoming the leading health tech player in MENA, and reinforces the great experience our customers have with MedIQ Solutions,' the platform said in a LinkedIn post on May 4.
'With fresh capital, a focused team, and a purpose-driven founder, MedIQ is now primed to scale across the GCC to become a regional leader,' it added.
The company, which expanded into Saudi Arabia in 2023, said it will use the funding to strengthen its technology stack, scale operations in the Kingdom's health tech market and support entry into Qatar and neighboring Gulf markets.
In an interview with Arab News in 2023, Dr. Siddiqui expressed her desire to see the platform expand across GCC countries.
Siddiqui had said women were the bulk users of MedIQ's products as it is usually hard for them to visit hospitals without male companions in Pakistan and the Middle East.
'According to the figures which we have, about 74 percent of our users are women and [the] women having children or dependents such as older parents,' she had said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
an hour ago
- Arab News
Lean teams up with Plug and Play to advance health innovation in Kingdom
As part of its ongoing efforts to expand international collaboration and accelerate innovation in the healthcare sector, Lean Business Services, a leading national enabler of digital health solutions and a Public Investment Fund company, has signed a strategic memorandum of understanding with global innovation platform Plug and Play, renowned for its startup acceleration programs. The agreement was signed during the official ministerial visit to the US led by Abdulaziz Al-Rumaih, vice minister of health. The partnership will establish a scalable and sustainable health innovation ecosystem in Saudi Arabia by launching acceleration programs for startups specializing in digital health and artificial intelligence, as well as creating innovation hubs that empower the next generation of health technologies across the Kingdom and the wider region. The MoU was signed at Plug and Play's headquarters in San Francisco by Mohanned Alrasheed, CEO of Lean, and Saeed Amidi, CEO of Plug and Play. Commenting on the collaboration, Alrasheed said: 'At Lean, we believe that true innovation begins with building strong international innovation networks. Our partnership with Plug and Play marks a strategic step toward creating a fertile environment for health entrepreneurship in the Kingdom and driving digital solutions that can meet the future needs of healthcare, both locally and globally.' Amidi added: 'We're incredibly excited about our partnership with Lean and the opportunity to showcase our shared vision to the world. Our teams will be working closely together to build something truly impactful that blends innovation, investment, and global collaboration to shape the future of healthcare and AI.' As part of the visit, the delegation from the Ministry of Health and Lean met with leaders from major technology companies, including Apple and Google, to explore the latest advancements in smart health devices, AI-driven solutions, and health data analytics. The discussions focused on potential integration opportunities with Saudi Arabia's national healthcare systems. The tour also included visits to leading startups specialized in accelerating drug discovery and early disease detection using AI. The delegation also visited Stanford Biodesign Labs to explore innovation support models in medical device design and biomedical engineering. This milestone reflects Lean's strong commitment to its role as a digital enabler in the health sector. It aligns with Saudi Arabia's Vision 2030 goals to build an innovative, sustainable, and innovation-driven healthcare ecosystem. Through global partnerships, Lean continues to lead digital transformation efforts, leveraging technology to deliver more efficient, human-centered, and high-quality health experiences to communities across the Kingdom.
Argaam
4 hours ago
- Argaam
Arab Sea signs contract with KAU hospital
Logo of Arab Sea Information Systems Co. Arab Sea Information Systems Co. signed a contract on July 18 with King Abdulaziz University (KAU) Hospital for the managed services project to operate the computer. In a Tadawul statement, the company said the contract is valued at SAR 17.24 million, including value-added tax (VAT). The financial impact will be reflected in the financial statements from 2025 to 2028, Arab Sea said, noting that there are no related parties in the deal. According to data available with Argaam, Arab Sea received a notice from KAU Hospital for this 36-month project award.
Arab News
a day ago
- Arab News
Biotech deal to enhance poultry safety, quality
Riyadh: The National Livestock and Fisheries Development Program has partnered with global biotech firm PhageGuard and Saudi poultry producer Tanmiah Food Co. to introduce advanced solutions promoting sustainable livestock production. The memorandum of understanding, signed in the presence of Vice Minister Mansour Al-Mushaiti, supports Saudi Arabia's goal to improve product quality and competitiveness locally and globally. The deal aims to enhance the quality and safety of local products by adopting innovative solutions that reduce health and environmental risks, the Saudi Press Agency reported. Under the MoU, PhageGuard will provide its biotechnology solutions through its local agent, Portalis Capital, to Tanmiah Food Co., which will implement and localize these technologies in the Saudi market. The deal supports poultry sector development, boosts operational and production efficiency, and fosters a knowledge- and innovation-driven livestock industry, the SPA reported. It focuses on bacteriophage technology as a biological alternative to traditional antibiotics, addressing concerns over antibiotic-resistant bacteria. These phages target Salmonella bacteria, helping reduce its spread, lower antibiotic use and promote safer food production. Applying this technology will help mitigate foodborne illness risks from salmonella in poultry and eggs, enhancing product quality and safety and strengthening competitiveness in local and global markets.
